Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ICE Publishes Q3 2026 Earnings Call Transcript

ICE Publishes Q3 2026 Earnings Call Transcript

BitgetBitget2026/10/30 04:02
  • ICE's October 29, 2026, third-quarter earnings call featured CEO Jeffrey Craig Sprecher, CFO Warren Gardiner and President Benjamin R. Jackson.
  • Adjusted earnings rose 18% to $2.02 per share; net revenue increased 15% to $2.8 billion.
  • Management expects the MarketAxess acquisition to close in the first quarter of 2027, earlier than planned, following Justice Department clearance.
  • Full-year recurring revenue growth forecasts reached approximately 9% for Exchanges and 8% for Fixed Income and Data Services, topping prior ranges.
  • Capital spending is now expected to total approximately $1.05 billion, largely reflecting a planned fourth-quarter Atlanta campus purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICE - Intercontinental Exchange Inc. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56

Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.

After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.

智通财经•2026/11/06 07:53

Hong Kong live music service provider Guitar Group applies for US IPO, aiming to raise $31 million

Guitar Group, a provider of music performance events, guitar-making workshops, and guitar repair services, submitted an application to the U.S. Securities and Exchange Commission (SEC) on Thursday, seeking to raise up to $31 million through an initial public offering (IPO).

智通财经•2026/11/06 07:50